Skip to main content
Clinical Trials/NCT06972225
NCT06972225RecruitingNot Applicable

Follow-up of MACE in Patients Treated With Drug-eluting Balloons Between 2010 and 2025; a Retrospective Study With Prospective Follow-up From an Institutional Database: EASY-drug-eluting Balloons

Olivier F. Bertrand1 site in 1 country1,500 target enrollmentStarted: June 10, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
1,500
Locations
1
Primary Endpoint
Major Adverse Cardiovascular Events

Study Overview

Brief Summary

Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults (>=18 years of age)
  • •Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025
  • •Identified in the institutional procedure database

Exclusion Criteria

  • •Incomplete or non-available data on the post-procedural clinical follow-up
  • •Procedures where other devices were used in combination with drug-eluting balloons.

Arms & Interventions

DEB

Intervention: DEB (Device)

Outcomes

Primary Outcomes

Major Adverse Cardiovascular Events

Time Frame: within 10 years of inclusion

defined as: * Cardiovascular death * Myocardial infarction * Target vessel revascularization * Cerebrovascular event * Hospitalization due to heart failure

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Olivier F. Bertrand
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Olivier F. Bertrand

MD, PhD

Laval University

Study Sites (1)

Loading locations...

Similar Trials